ICGex
Pierre Romero et al.
EZH2mutations in follicular lymphoma distort H3K27me3 profiles and alter transcriptional responses to PRC2 inhibition
2023
doi: 10.1101/2023.01.02.522460
Yohan Gerber-Ferder et al.
Breast cancer remotely imposes a myeloid bias on hematopoietic stem cells by reprogramming the bone marrow niche.
2022
doi: 10.21203/rs.3.rs-2338323/v1
Martin F. Orth et al.
Systematic multi-omics cell line profiling uncovers principles of Ewing sarcoma fusion oncogene-mediated gene regulation
Cell Reports 2022, vol. 41, issue 10
doi: 10.1016/j.celrep.2022.111761
Kenza Nedara et al.
Relevance of the TRIAP1/p53 axis in colon cancer cell proliferation and adaptation to glutamine deprivation
Frontiers in Oncology 2022, vol. 12
doi: 10.3389/fonc.2022.958155
L. Orliaguet et al.
Early macrophage response to obesity encompasses Interferon Regulatory Factor 5 regulated mitochondrial architecture remodelling
Nature Communications 2022, vol. 13, issue 1
doi: 10.1038/s41467-022-32813-z
Eleonora Timperi et al.
Lipid-Associated Macrophages Are Induced by Cancer-Associated Fibroblasts and Mediate Immune Suppression in Breast Cancer
Cancer Research 2022, vol. 82, issue 18
doi: 10.1158/0008-5472.can-22-1427
Riccardo Gamba et al.
Enrichment of centromeric DNA from human cells
PLOS Genetics 2022, vol. 18, issue 7
doi: 10.1371/journal.pgen.1010306
Yujiao Zhang et al.
Genetic inhibition of CARD9 accelerates the development of experimental atherosclerosis through CD36 dependent-defective autophagy
2022
doi: 10.21203/rs.3.rs-1834549/v1
Mathilde Saint-Ghislain et al.
MBD4 deficiency is predictive of response to immune checkpoint inhibitors in metastatic uveal melanoma patients
European Journal of Cancer 2022, vol. 173
doi: 10.1016/j.ejca.2022.06.033
Jessica Sriha et al.
BET and CDK Inhibition Reveal Differences in the Proliferation Control of Sympathetic Ganglion Neuroblasts and Adrenal Chromaffin Cells
Cancers 2022, vol. 14, issue 11
doi: 10.3390/cancers14112755